- Home
- NEE vs MRK Comparison
NEE vs MRK Comparison
Compare NEE & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEE | MRK |
|---|---|---|
| Founded | 1925 | 2000 |
| Country | United States | United States |
| Employees | 17400 | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.4B | 268.7B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | NEE | MRK |
|---|---|---|
| Price | $91.03 | $115.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 17 |
| Target Price | $93.69 | ★ $125.59 |
| AVG Volume (30 Days) | ★ 7.8M | 6.7M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | 2.73% | ★ 2.88% |
| EPS Growth | N/A | ★ 8.01 |
| EPS | N/A | ★ 7.28 |
| Revenue | N/A | ★ $65,011,000,000.00 |
| Revenue This Year | $15.96 | $3.73 |
| Revenue Next Year | $8.73 | $5.42 |
| P/E Ratio | $27.64 | ★ $16.23 |
| Revenue Growth | N/A | ★ 1.31 |
| 52 Week Low | $63.64 | $75.40 |
| 52 Week High | $96.21 | $125.14 |
Technical Indicators
Market Signals| Indicator | NEE | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 45.08 | 40.71 |
| Support Level | $89.54 | $113.27 |
| Resistance Level | $95.52 | $124.57 |
| Average True Range (ATR) | 1.52 | 2.85 |
| MACD | -0.25 | -0.42 |
| Stochastic Oscillator | 20.56 | 10.39 |
Price Performance
Historical ComparisonAbout NEE NextEra Energy Inc.
NextEra Energy's regulated utility, Florida Power & Light, is the largest rate-regulated utility in Florida. The utility distributes power to over 6 million customer accounts in Florida and owns 36 gigawatts of generation. FP&L contributes roughly 70% of NextEra's consolidated operating earnings. NextEra Energy Resources, the renewable energy segment, generates and sells power throughout the United States and Canada with nearly 40 GW of generation capacity, including natural gas, nuclear, wind, and solar.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).